RBC Cuts PTC Therapeutics (PTCT) Price Target by Nearly 20%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to RBC Cuts PTC Therapeutics (PTCT) Price Target by Nearly 20%

PTC Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

February 29, 2016 4:01 PM EST

SOUTH PLAINFIELD, N.J., Feb. 29, 2016 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year ending December 31, 2015.

"We are shocked and disappointed to have received a Refuse to File (RTF) letter from the FDA regarding our NDA for Translarna, and we are engaging in dialogue with the FDA to determine a path forward," said Stuart W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc.  "Despite this recent setback, we achieved a number of key... More